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The prevalence and severity of asthma has increased in the last 20 years, and the greatest
increase has been seen among children and young adults living in U.S. inner cities. The reasons
for this increase are obviously complex, but include environmental exposures to allergens and
pollutants, changing patterns of medication, and the psychosocial stresses of living in poor inner-
city neighborhoods. This paper presents an overview of environmental, immunologic, and genetic
factors associated with asthma morbidity and mortality. This overview can be used to provide a
framework for designing an interdisciplinary research program to address the complexities of
asthma etiology and exacerbation. The strongest epidemiologic association has been found
between.asthma morbidity and the exposure of immunologically sensitive asthmatic patients to
airborne allergens. Our current understanding of the process of sensitization suggests that there
is a strong genetic predisposition to form IgE to allergenic proteins on airborne particles. Much of
this work has been conducted with animal models, but in a number of instances, specific
confirmation has been reported in humans. Sensitized individuals respond to inhaled exposure
with immediate mast-cell dependent inflammation that may be augmented by pollutant particles,
especially diesel exhaust particles. Relatively little is known about the methods of assessing
exposure to airborne pollutants, especially biologically active particulates. However, to examine
the relationship of morbidity in genetically predisposed individuals, it will be important to
determine the most relevant method of making this assessment. Key words: air pollution,
allergens, asthma, urban environment. - Environ Health Perspect 107(suppl 3):439-450 (1999).
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Within the United States, asthma
morbidity and mortality has increased dis-
proportionately among poor, minority chil-
dren living in the inner city (1-4). Poverty,
ethnicity, and residence in the inner city are
closely related in the Unites States, and
considerable effort has been directed at dis-
secting these factors. There seem to be defi-
nite racial differences in prevalence that
cannot be explained by socioeconomic sta-
tus. According to National Health and
Nutrition Survey (NHANES II) data (5),
the rate ofasthma among children 6 months
to 11 years ofage was 3.0% in whites, 7.2%
in African Americans. Although the rate of
asthma was related to age, gender, and resi-
dence in the inner city, even when adjusted
for these factors, the ethnic differences were
significant. Similarly, in the Six Cities Study
(6), the unadjusted prevalence ofasthma in
white children 7-14 years ofage was 4.8%
and 6.7% in blacks-differences that were
statistically significant after adjustment for
confounding variables. Hispanic children
also have a higher prevalence ofasthma (3).
Morbidity from asthma is also higher in
minorities (3), generally, but poverty seems
to explain these differences (7). Mortality
from asthma is as much as three times
higher in minorities (3), and the relation of
mortality to black and Hispanic ethnicity
has been found by some (2) but not all (8)
investigators to be explained by poverty.
Together, these studies suggest that the
three components ofethnicity, poverty, and
residence cannot be dissected easily, and
should be viewed together when trying to
understand riskfactors for asthma.
The reasons for these trends are obviously
complex and must include many factors that
have nothing to do with the environment. At
the same time, current evidence suggests that
environmental exposure is at least one ofthe
most important causative factors. In addition,
environmental exposures may be risk factors
(like other public health measures) that are
more amenable to change than are social or
psychosocial problems. Perhaps, as in provid-
ing clean water supply and immunizations,
we can introduce concrete measures that will
have broad impact on health through an
organized societal effort. This paper reviews
the data relating exposure to environmental
pollutants and airborne allergens and dis-
cusses the relationship ofthis exposure to
asthmaprevalence andmorbidity.
Background
In approaching our understanding of the
importance ofenvironmental exposure, the
model shown in Figure 1 is a useful guide.
In this model, environmental exposure to
allergens and air pollutants such as part-
iculate matter (PM), environmental tobacco
smoke (ETS), and ozone (03) affect a sus-
ceptible host, resulting in airway inflam-
mation and obstruction that leads to
respiratory morbidity. Underlying and
influencing each step ofthis process are soci-
etal susceptibility factors (e.g., psychosocial
stress, high smoking rates, inappropriate
medication use, inadequate resources, and
poor access to quality health care) that are
specific to the inner city and serve to
increase asthma morbidity. Another critical
factor that influences host susceptibility to
environmental stimuli is the genetic
background ofthe person exposed.
As seen in this diagram, both environ-
mental allergen exposure and pollution can
increase asthma morbidity. Environmental
allergen exposure induces inflammation
through two steps. A person with the
appropriate genetic susceptibility develops
specific IgE antibody to the allergenic
protein following repeated or prolonged
exposure. We currently believe that poly-
morphisms of a number of genes coding
for critical regulatory proteins are responsi-
ble for the genetic susceptibility to sensiti-
zation to environmental allergens seen in
patients with asthma. Once sensitized, the
patient is susceptible to acute asthma
episodes in response to very small expo-
sures of airborne allergens (9). Pollutants,
both 03 (10,11) and PM (12), are associ-
ated with direct effects on the asthmatic
airway and with indirect synergistic effects
on allergic sensitization and inflammation.
Underlying these processes are important
social or psychosocial factors that increase
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Figure 1. A model of the pathways in which environ-
mental exposures and individual susceptibility interact
to lead to symptomatic asthma.
susceptibility in poor inner-city residents.
Other influences include impaired access to
good medical care for acute or chronic
treatment ofasthma, inappropriate use of
beta adrenergic agents, and emotional
stress, depression, and anxiety.
A large number ofcross-sectional, often
population-based studies have described the
association between prevalent asthma and
presence or history ofenvironmental expo-
sures. Observations about the possible effect
of dampness and mold problems was
reported from such studies conducted in the
United States (13,14), Canada (15), and
Finland (16). Environmental tobacco
smoke (17), gas cooking, and presence of
pets have also been associated with asthma
in cross-sectional studies. In a strictly cross-
sectional study, the causal inference is based
on a comparison of the prevalence of
asthma in subjects currently exposed and
unexposed. The major weakness of this
approach is the uncertainty in temporality,
which is an important criterion ofcausality;
i.e., the cause has to precede the effect. Use
of past exposure data from other sources
such as monitoring stations, emission
records, traffic statistics, or information on
emission sources (such as building charac-
teristics or surface materials) that most likely
has not changed over time could partly
resolve this critical issue oftime sequence.
An example of a case-control study
with prevalent cases of asthma is a study
carried out in the Netherlands to assess the
role of sensitization to dust mites and
molds in chronic respiratory symptoms and
asthma (18). With the use of a screening
questionnaire, 78 cases with asthma and
257 controls without chronic respiratory
symptoms were selected from a cross-section
of7,632 children from 38 schools. In this
study, the presence ofasthma was weakly
associated with observed dampness and
mold in the home in all children, but the
association was stronger in a subgroup with
elevated serum IgE to dust mites and/or
mold. Prevalent case-control study allows a
more efficient use ofavailable resources, but
shares some of the limitations of causal
inference with cross-sectional studies.
In a longitudinal study, the outcome is
defined as a new or incident case ofasthma.
Exposed and unexposed populations are
followed over time, and incidence rates of
asthma are compared. These studies can
also address the effects ofcumulative expo-
sures or exposures during specific periods of
time believed to be relevant, e.g., fetal expo-
sure or exposure in early childhood. Two
examples oflarge prospective cohort studies
are the Tucson Cohort Study and the Oslo
Birth Cohort Study. In the Tucson study, a
total of 1,246 newborns were enrolled in
the study between May 1980 and January
1984, representing 78% ofeligible infants.
These children were followed 3 years for
lower respiratory tract illness, and at 6-year
follow-up, questionnaire and skin prick
testing were applied. The Oslo Birth
Cohort Study was established by recruiting
3,754 children born in Oslo, Norway, dur-
ing a period of 15 months in 1992-1993.
Information on the child's health and envi-
ronmental exposures were collected at birth
and when the child was 6 months ofage
(follow-up rate = 95%), 12 months (92%),
18 months (92%), 24 months (81%), and
4 years. The effect ofexposure to ETS on
the risk ofdeveloping bronchial obstruction
in the first 2 years oflife was assessed (19).
The risk of bronchial obstruction was
increased in children exposed to ETS, with
an adjusted odds ratio (OR) of 1.6 [95%
confidence interval (CI) = 1.3-2.1]. The
effect was seen for maternal smoking alone
(OR = 1.6; 95% CI = 1.0-2.6), paternal
smoking alone (OR = 1.5; 95% CI =
1.1-2.2), and both parents smoking (OR =
1.5; 95% CI = 1.0-2.2). A longitudinal
study with prospective collection ofexpo-
sure information provides valid information
for causal inference, ifthe follow-up rates
are sufficiently high or random to protect
from selection bias.
In an incident case-control study,
only newly identified cases ofasthma are
recruited as cases with appropriate con-
trols at risk of asthma selected from the
source population that produced the cases.
Infante-Rivard carried out a case-control
study ofasthma in Quebec (17). The 457
cases of children with a newly diagnosed
asthma were recruited from a hospital
emergency room. Controls (n = 57) were
chosen from welfare files and were matched
with case children on age and census tract.
Mother's heavy smoking (OR = 2.77; 95%
CI = 1.35-5.66), use ofa humidifier in the
child's room (OR = 1.89; 95% = CI
1.30-2.74), and the presence ofan electric
heating system in the home (OR = 2.27;
95% CI = 1.42-3.65) were found as envi-
ronmental determinants of asthma. The
presence ofother smokers in the home was
not quite significant (OR = 1.82; 95% CI =
0.98-3.38). Another case-control study of
Norwegian infants (20) demonstrated that
bronchial obstruction was related to the
presence ofpolyvinyl chloride flooring (OR
= 1.89; 95% CI = 1.14-3.14) and textile
wall materials (adjusted OR =1.58; CI =
0.98-2.54) compared with a reference cate-
gory ofwood/parquet floor and painted
walls and ceilings in the home.
Environmental Pollutants
and Asthma
It has been suggested that urban pollution
might contribute to increased asthma mor-
bidity in the inner city. However, most
ambient pollutants have declined steadily
in U.S. cities (8) at the same time that
asthma morbidity and mortality have
increased. This does not exclude the
importance ofindoor pollutants, but much
less published data is available regarding
indoor pollutants.
Among indoor pollutants, ETS is most
closely linked with increased asthma preva-
lence and morbidity (6,9,21). In a general
population survey, smoking exposure
is similar among Caucasians, African
Americans, and Hispanics in the United
States. As reported from the Six Cities
Study (6), cigarette consumption ofover a
pack a day was reported by 29.9% ofwhite
mothers and 16.8% ofAfrican American
mothers. The same study reported smoking
by 2.4% of 14-year-old white boys, 11.7%
of white girls, 4.1% of black boys and
6.7% ofblack girls. These figures represent
the total population and do not separate
ethnic groups by income. Although no
direct comparisons between middle-class
and inner-city populations are available, a
study in an urban emergency room (ER)
may provide figures for inner-city popula-
tions. In this study, over 50% of the chil-
dren had at least one smoker in their
homes, and over 38% had elevated urinary
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cotinine compatible with heavy exposure
to ETS (9). Similar findings were found in
eight urban medical centers in the National
Cooperative Inner City Asthma Study
(NCICAS). In this study, 59% ofthe fami-
lies included at least one smoker, 39% of
the primary caretakers smoked, and urinary
cotinine was elevated (above 30 mg/gm
creatinine) in 48% of the children. These
figures suggest that exposure to ETS in the
home is more common in inner-city
homes, but it is not known how important
this is as a cause ofincreased morbidity.
Another indoor pollutant considered in
relation to asthma is nitrogen dioxide
(NO2). NO2 is an industrial pollutant that
is generated as a by- product of hydro-
carbon combustion and is considered to be
an important component ofurban smog. It
is generated in homes by gas stoves and
space heaters, but indoor concentrations
are rarely elevated to levels that are consid-
ered health risks. Indoor NO2 was mea-
sured in the NCICAS and was as high as
480 parts per billion (ppb), with 24% of
the families exposed to levels of40 ppb or
greater (22). These excessive levels were
thought to relate to the gas stoves used by
89% of the families and to the fact that
24% ofthe kitchens did not have function-
ing windows. To put this in context, the
U. S. Environmental Protection Agency
(U.S. EPA) air standards consider annual
average levels of50 ppb to constitute a risk
factor for acute and chronic lung disease.
Computer modeling ofdata from the Six
Cities Study demonstrated that levels over
30 ppb would result in annual exposures of
> 50 ppb (23). Thus, inner-city homes
frequently contain levels of an important
pollutant in excess of U.S. EPA environ-
mental standards, and could be expected to
contribute to asthma morbidity.
03 and PM have also been associated
with exacerbations ofasthma. Symptoms
and medication use have been associated
with ambient levels ofboth pollutants in
reports from Mexico City (24), Seattle (5),
and Atlanta (25). In a panel study ofasth-
matic patients, Delfino and colleagues (26)
showed a close correlation between daily
symptoms and exposure to O3, particulates,
and fungal spores. In addition, exposure to
03 (27) and residual oil fly ash [ROFA
(Diesel exhaust)] (10) increases airway
response to allergens in experimental airway
challenges. Although it is not clear that
inner city residents are exposed to unusual
concentrations ofthese pollutants, 03 equi-
librates rapidly between indoor and out-
door air, and this pollutant is clearly related
to urban rather that suburban areas. In
addition, particulates are much higher in
indoor air from homes with smokers and
higher ETS (28). In the absence of data
from inner-city homes, we can only specu-
late that 03 and PM pollutants interact
with indoor allergen exposures to increase
asthma morbidity.
Exposure to indoor allergens has recently
been suggested as a source of respiratory
morbidity. Between 70 and 90% ofchildren
and young adults with asthma have one or
more positive skin tests to aeroallergen
(22,29); the frequency is similar in asth-
matic patients in urban dinics (30-33). The
pattern ofspecific allergen sensitivity differs
from that in the general population, with a
higher frequency ofsensitivity to cockroach
and molds and less frequent sensitivity to
cats, dogs, and house dust mites. In the
NCICAS, children were skin tested using
a Multitest (Lincoln Diagnostics, Inc.
Decataur, IL) device for reaction to to 15
allergens (Dermatophagoidespteronyssinus,
Dermatophagoides farinae, alternaria,
helminthosporium, penicillium, cat, dog, rat,
mouse, German cockroach, American cock-
roach, oak, maple, grass, and ragweed
pollen). At least one positive skin test was
seen in 77% ofthe children; 47% had three
or more positive tests. The most common
positive skin test was alternaria (38%), fol-
lowed by cockroach (36%) and house dust
mite (35%). Allergy to rat (19%) and
mouse (15%) was almost as common as
allergy to cat (24%) and dog (16%). Most
of the children were sensitive to several
allergens (22).
The distinct pattern ofskin test reactivity
is mirrored by the pattern ofallergen expo-
sure found in inner-city homes. In an early
study from Baltimore, fungal contamination
was found in almost every sample ofsettled
dust (34). Recently, an elegant epidemio-
logic study found that exposure to outdoor
mold sporewas doselycorrelatedwith symp-
tom scores in agroup ofsensitized asthmatic
patients (10). In addition, cockroach aller-
gen has been implicated in several urban
studies. Call et al. (35) and Gelber et al.
(36) examined settled dust from inner-city
homes and found high concentrations of
cockroach allergen. In the NCICAS, settled
dust samples were collected from the
bedrooms, living rooms, and kitchens of
over 600 homes. Cockroach allergen was
detectable in 89% ofthe bedroom samples,
whereas mite and cat allergens were found
in only 49 and 86%, respectively (22).
Therefore, it appears that exposure to fungal
and cockroach allergens is characteristic of
inner-city homes, leading to more frequent
sensitization to these allergens than to house
dust mite andanimal dander.
A strong association was found in the
NCICAS between chronic morbidity from
asthma and the combination ofsensitiza-
tion and exposure (Figure 2). Using ques-
tionnaire data from baseline, 3, 6, and 9
months, it was found that the sensitized
and exposed children had greater asthma
morbidity in a number ofareas (11). For
example, the rate ofhospitalization in this
group is almost three times higher (0.37
hospitalizations per child per year) and
unscheduled visits are almost twice as fre-
quent (2.56 visits per child per year) in
these children compared to those who were
either not sensitized or not exposed. These
differences are significant (p< 0.01) even
when adjusted for gender, family history
and smoking exposure. Similar associations
were not found for either house dust mite
or cat allergen.
Accessto Medical Care
Early in the 1980s a survey reported that
nearly 50% ofschool-age children who had
active asthma received their care for asthma
only through the ER, and that 58% ofthese
children had had at least 1 ER visit for
asthma in the past 6 months (37). Almost
all families in the NCICAS reported having
a place for routine care, although 53.4%
found it difficult to obtain follow-up care
for acute attacks. Most (73.1%) paid for
their care through Medicaid. Routine care
was much more likely to be delivered in a
neighborhood health clinic or university
pediatric dinic, and acute care was delivered
predominantly in the ER (22,26). This pat-
tern was the same reported in a nationwide
cross-sectional survey, the National Health
Interview Survey, which included compara-
tive data for more affluent families (38). In
that survey, poor families were more likely
to attend a neighborhood health clinic (15.1
vs 1.6%) or a hospital-based clinic (11.1 vs
2.8%) andwere four times more likely to go
to an ER for their acute asthma care.
Although care at these sites is not necessarily
bad, this pattern is likely to lead to more
fragmented care. In addition, it creates the
need to travel to several sites and makes
telephone advice more difficult, especially
since 25-30% ofinner-city families do not
have atelephone in the home (39).
Patterns of Medication
Medication recommendations for the
treatment ofchronic asthma have changed
a great deal in the last decade. Current
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therapeutic guidelines (12,40) include daily
anti-inflammatory medications such as cro-
molyn, nedocromil, and inhaled steroids for
all patients with moderate to severe asthma
and for any patient who requires daily treat-
ment with a beta adrenergic agonist for
asthma symptoms. Medications used by
children in the inner city are similar to
those used in the general population
(22,27,41,42). In the NCICAS, 51% of
families reported that their child relied only
on beta adrenergic agonists for asthma and
that 66% included beta agonists in treat-
ment (22). Daily theophylline use was
reported by 19% of the NCICAS school-
children, and 28% reported using inhaled
steroids and cromolyn. These figures com-
pare to national asthma prescription figures
for children in 1993 of71% beta adrener-
gic agonists, 7% theophylline, and 22%
cromolyn, nedocromil, or inhaled steroids
(43). This pattern of reliance on beta
adrenergic agonists alone could lead to
more unstable asthma (41). Both the NCI-
CAS and a Baltimore/Washington survey
(44) found that many children with asthma
in the inner city took no medication for
their asthma, despite frequent symptoms,
ERvisits, and absences from school.
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degrees identified an association, misclassi-
fication of nondifferential exposure, con-
founding, and model specification limit
causal inference to the individual (57). It
has been shown that the more accurate the
exposure measure (progressing from central
site ambient monitoring to microenviron-
mental measurements to personal exposure
monitoring), the larger is the effect that
can be detected (58). The need for epi-
demiologic studies that rely on more direct
exposure surrogates has been highlighted
by Phalen and McClellan (59).
The goal ofthe exposure assessment as a
part ofan epidemiologic study is to estimate
and properly classify exposure with respect
to environmental agents suspected ofcaus-
ing asthma. This can be achieved through
direct and/or indirect assessment (60,61). A
direct assessment entails monitoring the
individual, using samplers that can be
attached or worn by the individual. The
advantage ofthe assessment is that it pro-
vides the single best measurement ofindi-
vidual exposure (62). The disadvantage of
personal monitoring is that it can be costly
and presents a burden to the subject that
can adversely affect response rate. Indirect
assessment relies on measurements in one or
more microenvironments combined with
time/activity data in a model thatweighs the
microenvironmental concentration by the
time the individual spent in that microenvi-
ronment (61-63). This approach has been
successfully employed in a number of air
pollution studies (64-66). The major
advantage to this approach is that the sub-
ject is not required to carry apersonal moni-
tor. This advantage comes at the cost of
decreased accuracy ofthe exposure estimate.
Because it includes indoor air where chil-
dren spend most oftheir time, it is believed
that the approach will capture most ofthe
variabilityofindividual exposures.
Efficiency in design can be achieved by
combining indirect and direct assessment
and nesting personal monitoring within the
microenvironmental assessment. This com-
bined approach is advocated and conceptu-
ally described by Duan and Mage (67) and
applied to NO2 by Leaderer et al. (65). This
approach addresses the practical limitations
(e.g., cost and burden) ofmeasuring expo-
sure in a large-scale epidemiologic study in a
scientifically defensible fashion. The concen-
tration ofpollutants in microenvironments
not measured (i.e., school and other) can be
estimated from indoor/outdoor data from
nonsource homes. Ifsource activity (e.g.,
smoking, cooking, burning) is reported for
a nonmeasured microenvironment, the
concentration can be estimated based on
published source models (60,68).
The home is the single most important
environment for assessing exposure, as peo-
ple spend most of their time there, there
are large and unique indoor sources (e.g.,
cooking, animals, mites, smoking, dust
resuspension), and ventilation with out-
door air is limited. A recent report on
human activity patterns show that school-
age children spend most of their time
indoors at home (68%). School is the next
most important microenvironment, occu-
pying 15% oftheir time on average (69).
Central site ambient monitoring by itself
provides a very poor surrogate for individ-
ual exposure for most air pollutants
(23,64,69,70,71). This is particularly true
for the pollutants of greatest concern for
asthma, including bioaerosols, airborne
particles, NO2, 03, and ETS.
Particle exposure is especially complex
because oflarge spatial and temporal vari-
ability in air concentrations, numerous and
varied sources, and an observed phenomena
ofan increasing concentration gradient in
the immediate proximity ofthe individual
("personal cloud") (72). In addition, parti-
cles are highly variable in shape, size, den-
sity, and chemistry. Airborne particles are
formed through mechanical and combus-
tion processes for which there are myriad
sources indoors and out (73,74). There is
consistent and convincing evidence that
smoking is the single largest indoor source
of fine particles in homes with smokers
(72). Smoking adds 25-45 pg/m3 to the
indoor PM2.5, with 1-2 pg/m3 coming
from each cigarette when averaged over a
24-hr period. Source strength forsmoking is
estimated at 12.7 ± 0.8 (SE) mg/cigarette
(75). Cooking is the second largest identifi-
able indoor source contributing 10-20
pg/m3. The particle TEAM (total exposure
assessment methodology) study in Riverside,
California, showed that, on average, across
all homes (smoking and nonsmoking), 76%
of the measured indoor air particulate
(PM1o) was from outdoor sources (76).
A strategy ofrelying on indoor air as an
exposure surrogate is justified based on the
recognition that human contact with air
contaminants is more a function ofsources
and activities in homes and neighborhoods
and less a function oflarge sources, their
releases to the ambient environment, and
resulting ambient air contamination (72).
This perspective is substantiated by
exposure studies that show that individual
exposure is poorly predicted by the con-
centration ofparticles outdoors, whereas a
much stronger correlation occurs with
indoor air measurements. For a population-
based sample (n = 178) in Riverside,
California, Ozkaynak et al. (76) reported
R2 values of0.40 and 0.65 for the regres-
sion ofindoor or personal PM1o for day and
night, respectively. Dockery and Spengler
(77) reported an R2 value of0.51 for the
same regression for PM3.5 measured on 37
subjects in Watertown, Massachussetts, and
Steubenville, Ohio. The R2 value increased
to 0.57 when indoor and outdoor concen-
trations were included in a model that
weighted these concentrations by the time
spent in each microenvironment. Using a
similar model for measurements ofPMIo,
Buckley et al. (78) reported a median corre-
lation of0.55 for 13 individuals monitored
over 14 days. In general, these assessments
ofmicroenvironmental measurements as
surrogates for estimating exposure are based
on adults. There are only emerging data on
these relationships in children (79) and no
data on children with asthma living in the
urban environment.
Numerous particle exposure studies
have recently been summarized to show
that central site ambient measurements pro-
vide a poor surrogate for an individual's
actual exposure, explaining only 0-25% of
the variation in personal measurements
(69,72,80). Outdoor air is an especially
poor surrogate in cross-sectional evaluations
where exposure variability is primarily dri-
ven by interpersonal differences. In con-
trast, in longitudinal studies where the
influence ofintrapersonal variability is less-
ened, outdoor central site measurements
appear to provide a better surrogate (78-
80). Ifthe variation in outdoor PM is not
predictive of the variations in personal
exposures, then use ofoutdoor central site
measurements will tend to misclassify expo-
sures, resulting in an attenuation in the
exposure-response relationship.
The use ofa single central site ambient
monitoring station for estimating the out-
door PM1o concentration for a community
or city is supported based on studies
(76,81,82) demonstrating high correlations
(PM1o: r> 0.7; PM2.5: r> 0.9) in measure-
ments across sites within a city (e.g.,
Philadelphia, Pennsylvania; Chicago,
Illinois; Los Angeles, California). Because
ofvast differences in factors known to be
important for exposure (e.g., time/activity
patterns, socioeconomic status, and source
use) between the populations for which
these relationships have been defined, there
is a clear need to define this relationship for
the urban asthmatic population.
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The epidemiologic evidence implicating
particle exposure as a causative agent in chil-
dren's asthma exacerbation is equivocal with
respect to the responsible size, e.g., PM1o,
PM3.5, PM2.5, or PM1.o. This assessment is
substantiated by a recent study where an
association between visits to asthma physi-
cians and increased levels of the coarse
fraction ofPM1o has been reported (51).
Size-selective sampling inlets are available
for measuring personal and microenvi-
ronmental particle concentrations (e.g.,
Personal Environment Monitor, MSP
Corporation, Minneapolis, MN) (83).
These inlets are well characterized and vali-
dated and have been successfully used in
other exposure studies (76,78). Compliance
with personal monitoring is of concern,
especially amongpopulation subgroups such
as children. Investigators have employed
motion sensors with logging capability bun-
dled with the personal monitor to evaluate
compliance by comparing the objective
motion datawith the time/activity question-
naire and expected activities such as school
attendance, sleeping, etc.
In contrast to airborne particles, the
determinants ofexposure to NO2 and O3
are less complex, as these pollutants are spe-
cific chemicals with well-characterized
physical and chemical properties. A major
outdoor source for nitrogen oxides is the
automobile (72). Indoor sources including
kerosene heaters and gas stoves. Their
impact on indoor air concentrations has
been well characterized. Anumber ofdiffer-
ent studies have shown that much of the
variability in NO2 personal exposure can be
explained by indirect assessment with
indoor and outdoor measurements in a
time-weighted model (23,64,65,71). A
similar situation exists for O3 that is formed
outdoors as a secondary pollutant. Because
there are no indoor residential sources, the
exposure variability is driven by outdoor
concentration gradients and building fac-
tors (e.g., air exchange, air conditioning)
affecting the decay of03. Liu et al. (70)
reported an indoor/outdoor ratio of
0.45 ± 0.23 and an R2 value of0.72 for a
microenvironmental model relying on
home indoor and outdoor, workplace, and
central site measurements in a study
conducted in State College, Pennsylvania.
ETS exposure can be effectively moni-
tored by measuring cotinine in urine (84)
or nicotine air concentrations. Urine coti-
nine is an effective biomarker for classify-
ing children from homes with and without
smokers (85). Urinary cotinine reportedly
provides a stable marker of exposure.
Henderson et al. (85) showed that urinary
cotinine levels were not affected by
collection time of day; Over a 1-month
period, sequential urine levels were highly
correlated (r> 0.88).
Interactions of Pollutants
and Allergens
The pathologic characteristics ofallergic
asthma are airway hyperresponsiveness,
eosinophilic inflammation, elevations in
serum IgE levels, and overproduction of
mucus. It is now well accepted that asth-
matic inflammation is driven by the expan-
sion ofallergen-specific T cells producing
type-2 cytokines (i.e., interleukin (IL)-4
and IL-5). Under this paradigm, allergen
presentation results in differentiation
of CD4 T cells to a T helper cell (Th2)
cytokine-2 producing phenotype in allergic
individuals, whereas differentiation along a
Thl pathway is associated with normal
responses. An immunopathogenic role for
Th2 cytokines in asthma is suggested by the
fact that IL-4 and IL-13 modulate the
growth and differentiation ofmast cells and
regulates IgE synthesis (86,87), whereas
IL-5 controls the differentiation (88),
recruitment (89), and activation ofeosino-
phils (90). Mast cells and eosinophils both
elaborate a number ofbronchoactive medi-
ators that induce the airway obstruction
characteristic ofasthma.
With the recent understanding of the
importance ofCD4 T cells in the patho-
genesis ofasthma, much attention has been
paid to the potential role ofparticulates in
augmenting or initiating responses that may
lead to activation ofCD4 T cells. Although
few controlled human or animal studies
have examined the effects of real-world
PM exposure on allergen-driven airway
responses, recent studies usingdiesel exhaust
particulates (DEP) or ROFA have shown
enhancement ofallergic responses in suscep-
tible individuals. Forexample, Diaz-Sanchez
and colleagues have shown that nasal chal-
lenge of human asthmatics with DEP
markedly enhanced their IgE responses to
ragweed challenge and skewed cytokine pro-
duction to one ofa Th2-type pattern (91).
Similarly, studies in several animal models
have confirmed these findings using a vari-
ety ofsources of PM (i.e., ROFA, fly ash,
DEP) (92,93). For example, Takano et al.
(92) demonstrate that exposure to DEP
enhances allergen-driven airway hyperre-
sponsiveness and eosinophilic inflammation
in mice sensitized with allergen. In this
model, Th2 cytokine production in DEP-
exposed animals was elevated over and
above that seen with allergen exposure
alone. Gavett et al. (94) found similar
results in mice exposed to ROFA. These
studies suggest that PM may exacerbate
asthma by enhancing production ofTh2
cytokines in allergic individuals.
The mechanism(s) by which PM
induces pulmonary inflammation and
alters immune responses to allergens is cur-
rently unknown. Perhaps the simplest
explanation is that PM serves as a carrier to
transport allergens into the respiratory
tract. However, studies in which allergens
have been delivered by nonpulmonary
routes show that the effects ofPM on aller-
gic responses are not solely due to its
potential to serve as a carrier for allergens
(95). On the other hand, exposure to PM
or its components has a number ofeffects
on macrophages and B cells that may aug-
ment their responsiveness to allergen expo-
sure. Specifically, DEP induces expression
of the costimulatory molecule CD80 in
both human lavage cells and in the human
macrophage cell line (THP-1) (96). CD80
binds with high affinity to its coreceptor
CD28 on T cells and results in costimula-
tion ofT cells. Thus it is conceivable that
PM could alter the response ofthe host to
ubiquitous allergens by providing required
co-stimulatory signals to enhance activa-
tion ofT cells. A potential explanation for
DEP effects on IgE production may be
through its documented ability to directly
enhance IgE production in normal human
tonsillar B cells and peripheral blood B
lymphocytes (92). The results of these
studies suggest that perhaps the IgE-
enhancing effects ofDEP may result from
direct effects on B lymphocytes.
Another potential mechanism by which
PM may alter immune responses is via the
induction of cytokine and chemokine
production by the airway epithelium. For
example, exposure to PM induces the
production of several proinflammatory
cytokines including IL-6, IL-8, and tumor
necrosis factor alpha (TNF-a) by epithelial
cells (97). Each of these cytokines has
potent proinflammatory effects in the lung.
IL-6, in particular, is a pleiotropic cytokine
that elicits numerous biologic responses
from a wide variety of tissues including
differentiation of B cells into antibody-
forming plasma cells, differentiation of
T cells, and maturation ofmegakaryocytes
and stimulation ofthe production ofacute-
phase proteins by hepatocytes. PM-
induced IL-6 production can be mimicked
by exposure ofthese cells to vanadium, one
of the major components of ROFA (98).
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As vanadium is a well-known tyrosine
phosphate inhibitor, exposure of the
epithelium or other lung cells to it could
play an important role in the activation,
responsiveness, and/or production ofmany
immunologically active molecules (99).
Several studies have suggested that
perhaps reactive oxygen species generated
as a result ofPM exposure may mediate the
biologic effects of PM on the respiratory
tract. For example, Kumagai and col-
leagues demonstrated that DEP extracts
induce superoxide and hydroxyl radical
generation in lung microsome preparations
(100) and that the intratracheal effects of
DEP could be prevented by pretreatment
of animals with a polyethylene glycol-
modified superoxide dismutase (101). As
reactive oxygen species initiate intracellular
signaling pathways and transcriptional acti-
vation ofmany genes [i.e., immediate early
genes (c-fos, c-jun), cytokine genes,
chemokine genes], they may play an
important role in mediating the proinflam-
matory effects of PM in the respiratory
tract. Collectively these studies suggest that
PM may induce airway inflammation
through a variety ofmechanisms. As PM is
a complex mixture of organic and inor-
ganic components that varies from location
to location, the challenge for investigators
is to determine which components or mix-
tures ofcomponents in PM are responsible
for the biologic effects.
Although most studies have been
designed to determine whether particulate
exposure augments allergic symptoms in
susceptible populations, there is accumulat-
ing evidence that perhaps acute particulate
exposure can induce these responses in non-
allergically prone individuals. Notably,
DEP exposure of nonallergic individuals
induces elevations in nasal IgE levels con-
comitant with increases in the number ofT
lymphocytes in nasal washes (10). In addi-
tion, a general increase in messenger RNA
levels of both ThI and Th2 cytokines in
the nasal lavages has been noted. Studies in
mice also support the conclusion that PM
exposure in nonallergic individuals can
induce airway inflammation. For example,
Gavett et al. (102) demonstrated that expo-
sure to ROFA results in pulmonary inflam-
mation marked by increases in eosinophils,
neutrophils, and T cells in nonsensitized
rats. In addition, we have recently found
that exposure of naive mice from several
murine strains to particulate collected in
urban Baltimore induces airway hyperre-
sponsiveness and airway inflammation
irrespective oftheir susceptibility to allergen
exposure (unpublished data). Specifically,
we have found that both A/J mice who dis-
play a natural susceptibility to the develop-
ment of allergic airway responses when
exposed to allergens, and C3H/HeJ mice
who do not develop airway hyperrespon-
siveness and eosinophilic inflammation
when exposed to ambient urban particulate.
Taken together, these studies suggest that
exposure to ambient particulates may play a
role not only in exacerbation of existing
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allergic disease, but may also contribute to
the recent rise in the prevalence ofasthma.
Genetic Mechanisms of
Ozone-induced Inflammation
In many industrialized cities throughout the
world, oxidant air pollutants have become
an important public health concern. Among
these agents, 03 is the most potent. Over
150 million people live in communities
where the concentrations of03 approach or
exceed the national ambient air quality
standards of0.12 ppm (103).
In healthy human subjects, acute (2-6
hr) exposure to 0.08-0.75 ppm 03 causes
decrements in pulmonary function (104),
elicits the release ofbronchoactive chemical
mediators (105,106), and induces airway
inflammation in adults and children (106).
Further, a number ofepidemiologic studies
have demonstrated an association between
respiratory morbidity and mortality and 03
exposure (107,108).
Asthmatics may represent a particularly
susceptible subpopulation for the toxic
effects of03 exposure. Recent studies have
suggested that asthmatics may develop
greater 03-induced airway inflammation
than normal subjects. Basha et al. (109)
found statistically significant increases in
bronchoalveolar lavage concentrations of
IL-8, IL-6, and neutrophils in asthmatics
but not in nonasthmatics after an acute
exposure to 0.20 ppm 03 Scannell et al.
(110) also found greater 03-induced
inflammation and pulmonary function
changes in asthmatics compared with
normal, healthy subjects. Similarly,
McBride et al. (111) exposed asthmatic
and normal subjects to 0.24 ppm 03 and
demonstrated significant increases in neu-
trophils and epithelial cells in nasal lavage
in asthmatics but not normal subjects.
Association ofasthma exacerbations with
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Figure 3. Number of macrophages (A), PMN (B), lymphocytes (C), and epithelial cells (D) recovered by
bronchoalveolar lavage after 24-, 48-, and 72-hr exposure to 0.30 ppm 03 or air in C57BL/6J and C3H/HeJ mice.
Abbreviations: 03, ozone; PMN, polymorphonuclear leukocytes. n = 6-8 mice/strain/time point. Statistical compar-
ison of 03-exposed animals with respective chamber (air) controls: *p < 0.05. Statistical comparison of C3H/HeJ
with C57BL/6J: p< 0.05.
Figure 4. Total bronchoalveolar lavage protein concen-
tration in C57BL/6J and C3H/HeJ strains of mice fol-
lowing 24-, 48-, and 72-hr continuous exposure to 0.12
ppm ozone (A), 0.30 ppm ozone (B), or filtered air.
Symbols are as presented in Figure 3. Data from
Kleeberger et al. (116).
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03 exposure have been demonstrated in a
number of urban environments including
Atlanta, Georgia (33), and Mexico City,
Mexico (24). Other studies have demon-
strated strong association between asthma
and pollutant mixtures that include 03
and particulates (112).
Extensive literature exists regarding 03
damage at the organ and cellular level,
although the mechanisms of03 toxicity are
still not clear. A cascade mechanism has
been proposed that suggests that 03 reacts
with unsaturated fatty acids at the air-tissue
barrier and forms lipid ozonation products
that include aldehydes, hydroperoxides, and
Criegee ozonide (113). The lipid ozonation
products in turn activate lipases that lead to
production and release ofcell signal trans-
duction molecules and proinflammatory
mediators such as platelet activating factor
Antioxidant enzymes (e.g., glutathione
enzymes, superoxide dismutase, and cata-
lase) and nonenzymatic factors (e.g., ascor-
bic acid, ax-tocopherol) provide defense
against oxidative damage of airway lipid
membranes (114) by quenching 03 either
directly or through interaction with the
reactive oxygen species by-products of03.
There are clearly a number ofgenetic
steps that could lead to increased suscepti-
bility to 03 exposure. The inbred mouse is
an important model to examine these
steps, because controlled standardized
inbreeding has led to genetic homogeneity
that cannot be found or duplicated in
human populations. Linkage relationships
of homologous loci from human and
mouse indicate that highly significant
homology and gene order in chromosomal
structure has been maintained since the
divergence of the human and mouse.
Therefore, the identification ofchromoso-
mal location(s) ofthe gene(s) for suscepti-
bility to 03-induced inflammation (or
other airway response) provides the basis
for potentially localizing a homologous
gene in the human (115).
In inbred mice, two major phenotypes
can be distinguished by the magnitude of
inflammatory responses: susceptible strains
(e.g., C57BL/6J, B6) develop approxi-
mately 4- to 6-fold greater 03-induced
influx of neutrophils and approximately
2- to 3-fold greater lavageable protein than
resistant strains (e.g., C3H/HeJ, C3)
(Figures 3, 4). Initial genetic analyses sug-
gested that inflammation induced by suba-
cute 03 exposures in B6 and C3 strains of
mice was a quantitative trait, but the analy-
ses did not indicate the location of the
susceptibility loci (116,117).
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Figure 5. Frequency distributions of the number (x 103/mL) of lavageable polymorphonuclear leukocytes from
C57BL/6J (B6; n = 72) and C3H/HeJ (C3; n = 51) mice and their progeny after 48-hr exposure to 0.30 ppm ozone.
Data from Kleeberger(118).
Another approach to identifying the
susceptibility loci is to search for genetic
linkage ofthe responsivity phenotype with
microsatellites (simple sequence repeats)
distributed throughout the mouse genome.
It is important to emphasize that the
genomewide screen was designed to identify
linkage to any chromosomal intervals within
the entire genome that might contain the
genes that are polymorphic between B6 and
C3 mice and might account for differential
03-induced inflammation in these two
strains. Genomewide screening contrasts
with the candidate gene approach in which
loci are chosen a priori as likely mechanisms
that determine differential susceptibility to
03 in B6 and C3 mice. These might
include genes for antioxidant enzymes and
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Figure 6. Graphic representation of pvalues for link-
age (by x2 test) of ozone-susceptibility phenotype in
B6:BX and B6C3F2 animals, with microsatellite markers
surrounding the quantitative trait locus on chromosome
17. The pvalues (yaxis) are plotted against the mark-
ers studied in the correct order and genetic distance (x
axis). Data from Kleeberger(118).
any other genes that may confer differential
susceptibility to oxidant exposure. (e.g.,
antioxidant gene polymorphisms, differ-
ences in epithelial membrane polymor-
phisms, fatty acid content). With the
candidate gene approach, linkage is then
assessed between the phenotype ofinterest
and markers flanking the candidate genes or
the candidate genes themselves.
Using genome-screening procedures,
we identified a statistically significant
quantitative trait locus (QTL) on chromo-
some 17 in the interval between D17-
Mit125 and D17MitJO (Figures 5 and 6),
and a suggestive QTL on chromosome 11
between D]1Mit20 and D]1MitJ2 (118).
Within the chromosome 17 QTL are a
number ofcandidate genes: Tnf(TNF-a),
H2 (histocompatability loci), and Mcp6
and Mcp7 (mast cell proteases 6 and 7).
Interestingly, the chromosome 17 QTL is
similar to a QTL for airways hyperreactiv-
ity (119), an important asthma subpheno-
type. Homologous loci with conserved
synteny in the human genome are located
on chromosome 6p21.3. There are also a
number of candidate genes within the
chromosome 11 QTL that may contribute
to differential responsivity to inflammatory
effects of 03 exposure. These include a
cluster of CC chemokine genes including
the genes for T-cell-specific RANTES (reg-
ulated on activation, normal T cell exp-
ressed and secreted) (Scya5), monocyte
chemotactic proteins 1 and 3 (Scya2,
Scya7), and macrophage inflammatory
protein la and 1P (Scya3, Scya4). Human
homologs for these loci are located on
17ql 1.2 and this region has been impli-
cated in the pathogenesis ofasthma (120)
and other inflammatory diseases.
Studies are currently being directed to
utilize positional cloning and breeding
techniques to definitively identify the gene
or genes that determine differential suscepti-
bility to 03-induced lung inflammation and
injury in inbred strains of mice and to
search for homologs in the human genome.
Understanding the genetic basis ofresponse
to 03-induced inflammation will lead to
potential means for identification ofsuscep-
tible individuals and, subsequently, methods
for intervention to preventinjury.
Conclusion
Asthma is a classic example of a disease
caused by gene-environment interaction.
The need to understand this interaction
has been intensified by our recognition
that asthma is becoming increasingly com-
mon and severe in industrialized countries.
Our understanding of environmental
influences is still in its infancy, but we can
say that indoor exposures are more impor-
tant than ambient pollutants and that
bioaerosols containing allergenic proteins
are especially important. We understand
that certain particulate aerosols and 03,
known to cause inflammation individually,
may act synergistically to enhance acute
and chronic IgE-mediated inflammation.
As a consequence, environmental exposure
assessment undertaken in epidemiologic
studies must measure a variety of agents
simultaneously ifwe are to understand the
reality ofenvironmental exposure. Finally,
we understand that the environment to be
studied must include not only important
airborne pollutants and allergens but the
psychosocial milieu in which the asthmatic
patient lives. New genetic methods help us
to dissect the genetic basis ofthe increased
susceptibility in asthma to inflammation
caused by either IgE-mediated mechanisms
or those with no immunologic basis. Once
identified in animal studies, individual
genes can be confirmed in human popula-
tions and susceptible alleles sought, so that
preventive strategies can be focused on
susceptible individuals.
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